American Vanguard Co. (NYSE:AVD – Get Free Report) was the recipient of a significant growth in short interest in December. As of December 31st, there was short interest totalling 935,600 shares, a growth of 10.3% from the December 15th total of 848,300 shares. Based on an average daily volume of 321,300 shares, the days-to-cover ratio is currently 2.9 days. Approximately 3.5% of the shares of the stock are sold short.
American Vanguard Price Performance
Shares of American Vanguard stock traded up $0.06 during trading hours on Monday, reaching $5.08. The company’s stock had a trading volume of 344,848 shares, compared to its average volume of 304,015. The firm has a 50 day moving average price of $5.28 and a 200-day moving average price of $6.06. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.89 and a quick ratio of 0.79. The stock has a market cap of $146.17 million, a P/E ratio of -4.93 and a beta of 0.91. American Vanguard has a one year low of $4.26 and a one year high of $14.28.
Insider Buying and Selling
In related news, Director Steven D. Macicek purchased 12,000 shares of American Vanguard stock in a transaction on Friday, November 15th. The shares were bought at an average cost of $5.97 per share, for a total transaction of $71,640.00. Following the acquisition, the director now owns 31,218 shares in the company, valued at approximately $186,371.46. The trade was a 62.44 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 10.10% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On American Vanguard
Analysts Set New Price Targets
Separately, StockNews.com raised American Vanguard from a “sell” rating to a “hold” rating in a research note on Wednesday, September 25th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, American Vanguard currently has an average rating of “Moderate Buy” and a consensus target price of $16.67.
Read Our Latest Analysis on AVD
American Vanguard Company Profile
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Further Reading
- Five stocks we like better than American Vanguard
- Compound Interest and Why It Matters When Investing
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.